To corroborate the reproducibility of the LC-MS system, 10 L from extracted samples was pooled to produce quality control (QC) samples
For patients with BED who also have obesity or type 2 diabetes, tirzepatide could theoretically address multiple therapeutic targets simultaneously
Early side effects like nausea and bloating are common
Peri-lesional injection requires precise anatomical knowledge and a higher technical skill level, and the marginal benefit over subcutaneous delivery is not clearly established
Insights Imaging 8 (6), 537548
S, possono includere nausea, crampi addominali e, in rari casi, disturbi gastrointestinali